DPIIT recognised startup Government of India
Startup India
Trinix Pharma Private Limited - pharma in Dehgam, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹12.49 Cr
▲ 26% YoY
Net profit · FY 2024
₹17.26 Lakh
Net margin 1.4%
EBITDA · FY 2024
₹1.73 Cr
EBITDA margin 13.9%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹3.95 Cr
Issued & subscribed
Open charges
₹16.78 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
6
As per MCA filings
About Trinix Pharma Private Limited
Data last updated:
Trinix Pharma Private Limited is a private limited company based in Dehgam, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2018PTC101736. Its GSTIN is 24AAGCT7143Q1ZS (Gujarat).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.95 Cr. It is led by directors including Himank Chandravadan Shah and Pradip Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No.17 Jaliya Na Math, Dehgam Gandhinagar, Gujarat, India – 382305.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.49 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹17.26 Lakh (net margin 1.4%) and EBITDA of ₹1.73 Cr (EBITDA margin 13.9%). Revenue has grown at a compounded annual rate (CAGR) of 614% over three years.
As per MCA filings, the company has open charges of ₹16.78 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 3 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹3.3 Cr; the latest was in March 2023. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Petrocoat Speciality Chemicals Private Limited with revenue of ₹12.51 Cr.
Trinix Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0016088). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website towapharma.com.
Company details
CIN U24100GJ2018PTC101736
Registration Number 101736
Incorporation Date 10 April 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0016088
Key People
Himank Chandravadan Shah Director Pradip Srivastava Director Prashant Srivastava Director Recognitions & Rankings of Trinix Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0016088
Contact details
Trinix Pharma Private Limited's registered office is in Dehgam, Gujarat. Its website is towapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSurvey No.17 Jaliya Na Math, Dehgam Gandhinagar, Gujarat, India – 382305
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trinix Pharma Private Limited, buy the company report.
Comprehensive company report
Trinix Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Trinix Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Trinix Pharma Private Limited, buy the company report.
Financials of Trinix Pharma Private Limited
FY 2025 filings availableTrinix Pharma Private Limited reported revenue of ₹12.49 Cr (up 26% YoY) for FY 2024.
Revenue · FY 2024
₹12.49 Cr ▲ 26%
Net profit · FY 2024
₹17.26 Lakh margin 1.4%
EBITDA · FY 2024
₹1.73 Cr margin 13.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 614%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 67%
5 years · compounded
▲ 122%
Revenue has grown at a compounded annual rate (CAGR) of 614% over three years, including 26% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.9% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trinix Pharma Private Limited, buy the company report.
Board of directors of Trinix Pharma Private Limited
Trinix Pharma has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himank Chandravadan Shah | Director | 10 Apr 2018 | 8 Years 6 Months | Current |
| Pradip Srivastava Also directs: Caper Lifescience LLP | Director | 17 May 2019 | 7 Years 5 Months | Current |
| Prashant Srivastava Also directs: Caper Lifescience LLP | Director | 17 May 2019 | 7 Years 5 Months | Current |
| Vimalkumar Anilkumar Gupta Also directs: Caper Lifescience LLP, Zynex Lifescience LLP | Director | 10 Apr 2018 | 8 Years 6 Months | Current |
| Bhavik Arvindbhai Shah Also directs: Caper Lifescience LLP, Zynex Lifescience LLP, Kmah Lifescience Private Limited and 1 more | Director | 13 Jun 2024 | 2 Years 4 Months | Current |
| Anil Gupta Vishwambhardayal Also directs: Zynex Lifescience LLP | Director | 10 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Trinix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Petrocoat Speciality Chemicals Private Limited | ₹12.51 Cr (FY 2025) | 45.0% | Chengalpattu, Tamil Nadu, India | |||
| Meheruba Chemicals Private Limited | ₹12.51 Cr (FY 2025) | -6.0% | Palakkad, Kerala, India | |||
| Maddux Products Private Limited | ₹12.5 Cr (FY 2024) | 246.0% | Pune, Maharashtra, India | |||
| Hemani Crop Care Private Limited | ₹12.5 Cr (FY 2025) | -68.0% | Mumbai, Maharashtra, India | |||
| Aryan Crop Protection Private Limited | ₹12.5 Cr (FY 2024) | 97.0% | Nadiad, Gujarat, India | |||
| Trinix Pharma Private Limitedthis company | ₹12.49 Cr (FY 2024) | ₹17.26 Lakh | 1.4% | 26.0% | Dehgam, Gujarat, India | |
| Flow Ink and Coatings Pvt Ltd | ₹12.49 Cr (FY 2024) | -4.0% | Ahmedabad, Gujarat, India | |||
| Benzer Multitech India Private Limited | ₹12.48 Cr (FY 2025) | 22.0% | Khed, Maharashtra, India | |||
| Sangam Health Care Products Ltd | ₹12.48 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| Dalsons Crop Science Private Limited | ₹12.48 Cr (FY 2024) | 6.0% | Rajkot, Gujarat, India | |||
| H&H Health Care & Cosmetics Private Limited | ₹12.48 Cr (FY 2025) | 4064.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Trinix Pharma Private Limited, buy the company report.
Auditor
Trinix Pharma Private Limited is audited by Rinal Shah & Associates for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rinal Shah & Associates | FY 2021 | 145780 |
Shareholding
The shareholding of Trinix Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Trinix Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.78 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Feb 2025 | 101109316 | Others | ₹5.4 Cr | Open | |
| 25 Feb 2025 | 101109319 | Others | ₹1.52 Cr | Open | |
| 07 Sep 2020 | 100383932 | Canara Bank | ₹9.86 Cr | Open |
To see the full charge records of Trinix Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Trinix Pharma Private Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹3.3 Cr; the latest was in March 2023.
Total deals
4
Secondary share transfers
2
Rights issue
1
Funding round
1
Disclosed funding
₹3.3 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Rights issue | ₹60 Lakh | Investors: 4 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2021 | Funding round | ₹3.3 Cr | Investors: 4 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Trinix Pharma Private Limited has 6 court cases on record: 5 filed by Trinix Pharma, 1 filed against it. 3 cases are pending and 3 are disposed.
Total cases
6
Filed by the company
5
Filed against the company
1
Pending
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 0 |
| High courts | 3 | 1 | 3 |
Cases on record (3 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Special civil application | Filed by the company against Gujarat Medical Services Corporation Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Aveo Pharmaceuticals Private Limited Through Its Director Arvind Sharma | Pending |
| District court, kachchh at Bhuj, Gujarat | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Trinix Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trinix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trinix Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCT7143Q1ZS | Gujarat | Active | 14 Jun 2018 |
To see the full GST registrations and return filing status of Trinix Pharma Private Limited, buy the company report.
Recent activity
Trinix Pharma Private Limited has 8 board changes on record since 2018: 6 appointments and 2 cessations. The latest: Bhavik Arvindbhai Shah was appointed as Director on 13 Jun 2024.
AGM
Trinix Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 5.40 Cr registered on 25 Feb 2025 with Charge ID 101109316 was modified on 13 May 2025.
Charges
A charge with Others of Rs. 1.52 Cr registered on 25 Feb 2025 with Charge ID 101109319 was modified on 13 May 2025.
Filing
Trinix Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 5.40 Cr with Charge ID 101109316 was registered on 25 Feb 2025.
Charges
A charge with Others amounted to Rs. 1.52 Cr with Charge ID 101109319 was registered on 25 Feb 2025.
Charges
A charge with Canara Bank of Rs. 9.86 Cr registered on 07 Sep 2020 with Charge ID 100383932 was modified on 19 Nov 2024.
Appointed
Bhavik Arvindbhai Shah was appointed as Director.
Ceased
Nayanaben Arvindbhai Shah ceased to be Director.
Ceased
Bhavik Arvindbhai Shah ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 9.86 Cr with Charge ID 100383932 was registered on 07 Sep 2020.
Appointed
Pradip Srivastava was appointed as Director.
5 earlier events are in the company report.
Frequently asked questions
Trinix Pharma is an active private limited company based in Dehgam, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 2018 (8+ years old) and is registered under CIN U24100GJ2018PTC101736.
Trinix Pharma has 6 current directors:
- Himank Chandravadan Shah - Director
- Pradip Srivastava - Director
- Prashant Srivastava - Director
- Vimalkumar Anilkumar Gupta - Director
- Bhavik Arvindbhai Shah - Director
- Anil Gupta Vishwambhardayal - Director
The latest financial statements of Trinix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Trinix Pharma is 24AAGCT7143Q1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Trinix Pharma is U24100GJ2018PTC101736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trinix Pharma has 6 court cases on record: 5 filed by the company and 1 filed against it. 3 are pending. Most are in the district courts.
Trinix Pharma was incorporated on 10 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Trinix Pharma has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹3.3 Cr; the latest was in March 2023.
The peers of Trinix Pharma by revenue are Petrocoat Speciality Chemicals Private Limited, Meheruba Chemicals Private Limited, Maddux Products Private Limited, Hemani Crop Care Private Limited, Aryan Crop Protection Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhavik Arvindbhai Shah was appointed as Director on 13 Jun 2024. Nayanaben Arvindbhai Shah ceased to be Director on 12 Jun 2024. Bhavik Arvindbhai Shah ceased to be Director on 25 Aug 2023. Trinix Pharma has 8 board changes on record in total.
Yes, Trinix Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).